Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms

British Journal of Haematology

Volumn 130, Issue 4, 2005, Pages 561-567

  Murashige, Naoko ^a   Kami, Masahiro ^a   Kishi, Yukiko ^a   Kim, Sung Won ^a   Takeuchi, Masami ^b   Matsue, Kosei ^b   Kanda, Yoshinobu ^c   Hirokawa, Makoto ^d   Kawabata, Yoshinari ^d   Matsumura, Tomoko ^e   Kusumi, Eiji ^e   Hirabayashi, Noriyuki ^f   Nagafuji, Koji ^g   Suzuki, Ritsuro ^h   Takeuchi, Kengo ⁱ   Oshimi, Kazuo ^j  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b Kameda General Hospital   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TORANOMON HOSPITAL   (Japan)

^f NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^g KYUSHU UNIVERSITY   (Japan)

^h AICHI CANCER CENTER HOSPITAL   (Japan)

ⁱ CANCER INSTITUTE HOSPITAL   (Japan)

^j JUNTENDO UNIVERSITY   (Japan)

more..

Author keywords

Chemosensitivity; Disease progression; Graft versus lymphoma effect; Overall survival; Progression free survival

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RANIMUSTINE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CAUSE OF DEATH; CHEMOSENSITIVITY; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DONOR; DRUG MEGADOSE; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; GROUPS BY AGE; HEMATOLOGY; HEMATOPOIETIC STEM CELL; HUMAN; INFECTION; INTERSTITIAL PNEUMONIA; LEUKEMIA; LYMPH NODE IRRADIATION; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MULTIVARIATE ANALYSIS; MYELOABLATIVE CONDITIONING; NATURAL KILLER CELL; PATHOLOGIST; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; REDUCED INTENSITY CONDITIONING; RISK FACTOR; STATISTICAL ANALYSIS; T CELL LYMPHOMA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT RESPONSE; VEIN OCCLUSION; WHOLE BODY RADIATION; WORLD HEALTH ORGANIZATION; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; MIDDLE AGED; MORTALITY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROPORTIONAL HAZARDS MODEL; RISK;

ADULT; BONE MARROW TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROPORTIONAL HAZARDS MODELS; RISK; TRANSPLANTATION, HOMOLOGOUS;

EID: 24944436331     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05651.x     Document Type: Article

References (27)

1. Au W.Y. Lie A.K. Liang R. Kwong Y.L. Yau C.C. Cheung M.M. Ngan K.C. Lau W.H. Wong K.H. Yiu H.Y. Cheng H.C. Au K.H. Chan J.K. ( 2003) Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value. Annals of Oncology, 14, 1673 1676.
2. Bearman S.I. Appelbaum F.R. Buckner C.D. Petersen F.B. Fisher L.D. Clift R.A. Thomas E.D. ( 1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. Journal of Clinical Oncology, 6, 1562 1568.
3. Bishop M.R. ( 2003) The graft-versus-lymphoma effect: fact, fiction, or opportunity Journal of Clinical Oncology, 21, 3713 3715.
4. Chan J.K. Sin V.C. Wong K.F. Ng C.S. Tsang W.Y. Chan C.H. Cheung M.M. Lau W.H. ( 1997) Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood, 89, 4501 4513.
5. Chan J. Jaffe E. Ralfkiaer E. ( 2001a) Blastic NK-cell lymphoma. In: World Health Organization Classification of Tumours ( ed. by E. Jaffe N. Harris H. Stein J. Vardiman). IARC Press, Lyon Ralfkiaer E. ( 2001b) Extranodal NK/T-cell lymphoma, nasal type. In: World Health Organization Classification of Tumours ( ed. by E. Jaffe N. Harris H. Stein J. Vardiman). IARC Press, Lyon.
6. Chan J. Wong K. Jaffe E. Ralfkiaer E. ( 2001c) Aggressive NK-cell leukaemia. In: World Health Organization Classification of Tumours ( ed. by E. Jaffe N. Harris H. Stein J. Vardiman). IARC Press, Lyon.
7. Cheung M.M. Chan J.K. Lau W.H. Foo W. Chan P.T. Ng C.S. Ngan R.K. ( 1998) Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. Journal of Clinical Oncology, 16, 70 77.
8. Chim C.S. Ma S.Y. Au W.Y. Choy C. Lie A.K. Liang R. Yau C.C. Kwong Y.L. ( 2004) Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood, 103, 216 221.
9. Clift R.A. Buckner C.D. Appelbaum F.R. Bearman S.I. Petersen F.B. Fisher L.D. Anasetti C. Beatty P. Bensinger W.I. Doney K. Hill R.S. McDonald G.B. Martin P. Sanders J. Singer J. Stewart P. Sullivan K.M. Witherspoon R. Storb R. Hansen J.A. Thomas E.D. ( 1990) Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood, 76, 1867 1871.
10. Dominietto A. Lamparelli T. Raiola A.M. Van Lint M.T. Gualandi F. Berisso G. Bregante S. Di Grazia C. Soracco M. Pitto A. Frassoni F. Bacigalupo A. ( 2002) Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation. Blood, 100, 3930 3934.
11. Giralt S. Estey E. Albitar M. van Besien K. Rondon G. Anderlini P. O'Brien S. Khouri I. Gajewski J. Mehra R. Claxton D. Andersson B. Beran M. Przepiorka D. Koller C. Kornblau S. Korbling M. Keating M. Kantarjian H. Champlin R. ( 1997) Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood, 89, 4531 4536.
12. Imashuku S. Hibi S. Todo S. Sako M. Inoue M. Kawa K. Koike K. Iwai A. Tsuchiya S. Akiyama Y. Kotani T. Kawamura Y. Hirosawa M. Hasegawa D. Kosaka Y. Yamaguchi H. Ishii E. Kato K. Ishii M. Kigasawa H. ( 1999) Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplantation, 23, 569 572.
13. Izutsu K. Kanda Y. Ohno H. Sao H. Ogawa H. Miyazaki Y. Kawa K. Kodera Y. Kato S. Morishima Y. Hirai H. ( 2004) Unrelated bone marrow transplantation for non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program. Blood, 103, 1955 1960.
14. Jaffe E.S. Chan J.K. Su I.J. Frizzera G. Mori S. Feller A.C. Ho F.C. ( 1996) Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology. American Journal of Surgical Pathology, 20, 103 111.
15. Jones R.J. Ambinder R.F. Piantadosi S. Santos G.W. ( 1991) Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation. Blood, 77, 649 653.
16. Kim K. Kim W.S. Jung C.W. Im Y.H. Kang W.K. Lee M.H. Park C.H. Ko Y.H. Ree H.J. Park K. ( 2002) Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification. European Journal of Cancer, 38, 75 81.
17. Kwong Y.L. Chan A.C. Liang R. Chiang A.K. Chim C.S. Chan T.K. Todd D. Ho F.C. ( 1997) CD56+ NK lymphomas: clinicopathological features and prognosis. British Journal of Haematology, 97, 821 829.
18. Li C.C. Tien H.F. Tang J.L. Yao M. Chen Y.C. Su I.J. Hsu S.M. Hong R.L. ( 2004) Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer, 100, 366 375.
19. Nakamura S. Katoh E. Koshikawa T. Yatabe Y. Nagasaka T. Ishida H. Tokoro Y. Koike K. Kagami Y. Ogura M. Kojima M. Nara Y. Mizoguchi Y. Hara K. Kurita S. Seto M. Suchi T. ( 1997) Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. Pathology International, 47, 38 53.
20. Oshimi K. ( 2003) Leukemia and lymphoma of natural killer lineage cells. International Journal of Hematology, 78, 18 23.
21. Ratanatharathorn V. Uberti J. Karanes C. Abella E. Lum L.G. Momin F. Cummings G. Sensenbrenner L.L. ( 1994) Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood, 84, 1050 1055.
22. Saito T. Kanda Y. Kami M. Kato K. Shoji N. Kanai S. Ohnishi T. Kawano Y. Nakai K. Ogasawara T. Matsubara H. Makimoto A. Tanosaki R. Tobinai K. Wakasugi H. Takaue Y. Mineishi S. ( 2002) Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma. Clinical Cancer Research, 8, 1014 1020.
23. Slavin S. Nagler A. Naparstek E. Kapelushnik Y. Aker M. Cividalli G. Varadi G. Kirschbaum M. Ackerstein A. Samuel S. Amar A. Brautbar C. Ben-Tal O. Eldor A. Or R. ( 1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 91, 756 763.
24. Song S.Y. Kim W.S. Ko Y.H. Kim K. Lee M.H. Park K. ( 2002) Aggressive natural killer cell leukemia: clinical features and treatment outcome. Haematologica, 87, 1343 1345.
25. Suzuki R. Suzumiya J. Nakamura S. Aoki S. Notoya A. Ozaki S. Gondo H. Hino N. Mori H. Sugimori H. Kawa K. Oshimi K. ( 2004) Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells. Leukemia, 18, 763 770.
26. Suzuki R. Nakamura S. Suzumiya J. Ichimura K. Ichikawa M. Ogata K. Kura Y. Aikawa K. Teshima H. Sako M. Kojima H. Nishio M. Yoshino T. Sugimori H. Kawa K. Oshimi K. the NK-cell Tumor Study Group. ( 2005) Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement. Cancer (Epub ahead of print) Harada M. ( 2001) High-dose chemotherapy with hematopoietic stem cell transplantation is effective for nasal and nasal-type CD56+ natural killer cell lymphomas. Leukemia and Lymphoma, 42, 1297 1303.
27. Tanimoto T.E. Kusumi E. Hamaki T. Yuji K. Ueyama J. Miyakoshi S. Morinaga S. Kami M. Kanda Y. Ando T. Yoshihara S. Masuo S. Kim S.W. Nakai K. Tobinai K. Tanosaki R. Mineishi S. Takaue Y. Muto Y. ( 2003) High complete response rate after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in advanced malignant lymphoma. Bone Marrow Transplantation, 32, 131 137.